Moderna
MRNA
#275
Rank
A$125.82 B
Marketcap
A$315.15
Share price
-0.47%
Change (1 day)
634.61%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -A$4.46 Billion

According to Moderna 's latest financial reports the company's current earnings are A$2.21 Billion. In 2025 the company made an earning of -A$3.93 Billion, an increase over its 2024 earnings that were of -A$5.1 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$4.46 Billion13.56%
2025 -A$3.93 Billion-23.03%
2024 -A$5.1 Billion-8.22%
2023 -A$5.55 Billion-140.65%
2022 A$13.65 B-27.81%
2021 A$18.90 B-1911.15%
2020 -A$1.05 Billion44.7%
2019 -A$0.73 Billion28.63%
2018 -A$0.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.25 B-960.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.06 B-609.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$10.93 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-A$67.42 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$59.37 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.59 B-136.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-A$0.23 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA